Emergent BioSolutions, Inc. (EBS)
12.39
-0.57
(-4.40%)
USD |
NYSE |
Jan 12, 16:00
12.39
0.00 (0.00%)
After-Hours: 17:38
Emergent BioSolutions Market Cap: 650.72M for Jan. 12, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Black Diamond Therapeutics, Inc. | 149.84M |
| NovaBay Pharmaceuticals, Inc. | 1.695B |
| Palatin Technologies, Inc. | 13.64M |
| Theriva Biologics, Inc. | 7.355M |
| Oragenics, Inc. | 0.6974M |
Market Cap Related Metrics
| PE Ratio | 9.575 |
| PS Ratio | 0.8725 |
| Price to Book Value | 1.117 |
| Price to Free Cash Flow | 491.62 |
| Price | 12.39 |
| Earnings Yield | 10.44% |
| Operating PE Ratio | 5.933 |
| Normalized PE Ratio | 9.814 |